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Abstract:
Aims: Based on indirect methods, it has been suggested that both L-and T-type Ca 2+ channels mediate signalling in the renal afferent arteriole and that T-type Ca channels are involved in signalling in the efferent arteriole. However, Ca 2+ currents have never been studied in these two vessels. Our study was initiated to directly determine the type of Ca 2+ channels in these vessels for the first time, using patch clamp.
Methods and Results:
Native myocytes were obtained from individually isolated rat renal afferent and efferent arterioles and from rat tail arteries (TA). TA myocytes, which possess both L-and T-type Ca 2+ currents, served as a positive control. Inward Ca 2+ and Ba 2+ currents (I Ca and I Ba ) were measured in 1.5 mmol/L Ca 2+ and 10 mmol/L Ba 2+ , respectively, using the whole-cell configuration. By exploiting known differences in activation and inactivation characteristics and differing sensitivities to nifedipine and kurtoxin, the presence of both Land T-type Ca 2+ channels in TA myocytes were readily demonstrated. Afferent arteriolar myocytes exhibited relatively large I Ca densities (-2.0±0.2 pA/pF) in physiologic Ca and the I Ba was 3.6 fold greater. These currents were blocked by nifedipine, but not by kurtoxin and did not exhibit the activation and inactivation characteristics of T-type Ca channels. Efferent arteriolar myocytes did not exhibit a discernable voltage-activated I Ca in physiologic Ca 2+ .
Conclusions:
Our findings support the physiologic role of L-type Ca 2+ channels in the afferent, but not efferent, arteriole, but do not support the premise that functional T-type Ca 2+ channels are present in either vessel.
Introduction
The renal afferent and efferent arterioles regulate the inflow and outflow resistances of the glomerulus and thereby regulate the pressure within the intervening glomerular capillaries (P GC ). Afferent arteriolar constriction reduces P GC and, for example, prevents the transmission of systemic hypertension to the glomerulus. 1 A selective efferent vasoconstriction increases P GC and is essential in preserving glomerular filtration rate (GFR) when renal perfusion is compromised. 2 Considering their differing roles and the physiologic need for independent regulation, it is not surprising that these two vessels have quite distinct regulatory mechanisms. A key difference involves the types of Ca 2+ entry mechanisms present in each vessel.
Early studies examining the effects of Ca 2+ channel blocking agents on renal hemodynamics suggested that such agents act selectively on pre-glomerular resistance, increasing P GC and GFR. 3 This premise was confirmed as diverse approaches, developed to directly assess the effects of these agents on the renal microcirculation, demonstrated a preferential dilation of the afferent arteriole, and no effect on the efferent arteriole. 4, 5 Indeed, the efferent arteriole appears to be unique, in that not only is this vessel insensitive to L-type Ca 2+ blockers, but, with rare exceptions, 6,7 depolarization does not cause vasoconstriction or Ca 2+ entry. [8] [9] [10] Similarly, hyperpolarization, which attenuates afferent arteriolar vasoconstriction, presumably by reducing the activities of voltage-activated Ca 2+ channels, has no discernable effect on the efferent arteriole. 14 These considerations point to importance of studies that directly evaluate the voltageactivated Ca 2+ channels that are present in the renal afferent and efferent arterioles using patch clamp. To our knowledge the present study is the first to do so using single myocytes freshly dispersed from individually isolated afferent and efferent arterioles.
Methods
All The characteristics of the Ca 2+ channels present in native renal afferent (AA) and efferent (EA) arteriolar myocytes were evaluated using the whole-cell patch-clamp at room temperature (23ºC). Individual renal arterioles were isolated from the renal cortex (excluding the juxtamedullary area) of normal male Sprague-Dawley rat kidneys using the gel-perfusion technique. 8 Tissue was harvested under deep halothane anaesthesia (1.5-2% flow rate, assessed by the absence of paw withdrawal reflex) and animals were euthanized by exsanguination. Only relaxed myocytes isolated from afferent and efferent arterioles as previously described 8 were used in electrophysiological experiments. Myocytes from the rat tail artery (TA) were used as positive control, as both T-and L-type Ca 2+ currents are consistently reported in these cells (e.g. 16, 17 ). TA myocytes were dispersed from the tissue with the enzyme solution containing 2mg/ml collagenase NB8, 200U/ml collagenolytic protease, 2mg/ml dispase II and 0.8U/ml elastase III (30-35min, 37ºC ). All types of isolated myocytes were studied under identical conditions. Electrophysiological recordings were performed as described previously. (between -80 to +40 mV in 10 mV increments) followed by a test pulse (0 or -20 mV).
Current amplitudes at the test pulse were normalized and fit to a modified Boltzmann
, where V h and k h are half-inactivation potential and the slope factor of inactivation, and A is non-inactivating component of the current.
Data are expressed as the means using the standard error of the mean (s.e.m.). Differences between means were evaluated by paired or unpaired Student's t test. For multiple measurements, analysis of variance (ANOVA) followed by Bonferroni post-hoc test were applied to assess significance. Probabilities with p<0.05 were considered significant.
Results
At physiologic levels of extracellular Ca 2+ ( figure 2B . Although the general character of I-V curves for afferent and TA myocytes were similar, modest differences were discerned. Firstly, the peak I Ba density was significantly larger in the afferent myocytes no such shift was detected in the TA myocytes (Fig.2C) . Although the V a for the whole-cell I Ba of TA myocytes (0.8±0.4 mV) was significantly more negative than that of afferent myocytes (3.4±0.5 mV, p=0.0003) (Fig.2C) , the difference was quite modest. Accordingly, the presence of different Ca 2+ channel types could not be clearly discerned based only on the difference in the activation of the composite whole-cell current as was demonstrated in some VSMCs. [19] [20] [21] In addition to a more negative V a , T-type Ca 2+ currents exhibit rapid inactivation which is (Fig.3A, the current at the conditioning potential -20 mV shown in grey).
By contrast, TA myocytes subjected to the same protocol exhibited a significant leftward shift in the availability of the peak I Ba (V h =-23.1±1.6 mV) compared to that for I Ba at 100 ms (V h =-10.7±1.1 mV, n=12, p=0.00002, Fig.3D ). Also, significant changes in k a (11.4±0.6 mV vs 8.7±0.7 mV, p=0.0033)) and in A (0.25±0.03 vs 0.36±0.03, p=0.00001) for the peak and 100 ms I Ba , respectively, were found. These effects strongly suggest the presence of at least two current components in TA myocytes; with the peak I Ba containing both the T-and Lcomponents whilst I Ba at 100 ms is predominantly the L-type. The similarity between the half-inactivation potential for I Ba at 100 ms in TA myocytes and that for I Ba measured both at the peak and 100 ms in afferent myocytes supports the dominance of the L-type in the latter (compare Fig.3B and 3D ). The analysis of I Ba availability at -20 mV in TA myocytes (Fig.3D, filled triangles) where the T-component is dominant, shows even more striking difference with an over 30 mV negative shift in the availability (V h =-43.4±1.3 mV, k h =5.6±1.3 mV, A=0.36±0.04, n=9) compared to that for I Ba measured at 100 ms at 0 mV.
The size of I Ba at -20 mV in afferent myocytes was too small to derive meaningful availability dependence using this approach.
The presence of the fast inactivating T-type component can also be demonstrated by the analysis illustrated in figure 3E . These data depict difference currents obtained by subtracting I Ba at the test potential 0 mV following a conditioning step to -20 mV (when the current is predominantly L-type since the T-type is inactivated as illustrated in Fig.3D ) from that obtained after a conditioning step to -80 (when both currents are available). As shown in figure 3E , a fast-inactivating T-type current is readily demonstrated in the TA myocytes but not in afferent myocytes. The non-inactivating difference current in both cell types is due to the partial inactivation of L-type channels at -20 mV (Fig.3B and 3D) . Furthermore, the analysis of the current kinetics of the mean I Ba densities measured at 500 ms conditioning A comparison of the steady-state half-activation parameters disclosed a significant nifedipineinduced leftward shift in V a in TA myocytes, but not in afferent myocytes (Fig.4E ). We were able to conduct the availability at 0 mV test potentials in two nifedipine-treated TA myocytes and found V h to be -38.9 and -37.5 mV, values similar to those seen in the absence of nifedipine at test potentials of -20 mV (Fig.3D ). kurtoxin caused a small but similar decrease in both the peak and I Ba at 100 ms (Fig.5A) , whereas in the TA myocyte the inhibitor completely blocked an initial rapidly inactivating component of I Ba but had little effect on I Ba at the end of step depolarization (Fig.5E ).
Figures 5B and 5F compare the mean kurtoxin-sensitive currents (control minus kurtoxin-treated) and the mean control difference currents (control minus time controls without kurtoxin) in afferent and TA myocytes, respectively illustrating the effects of kurtoxin and current run-down.
Note, that an inactivating, kurtoxin-sensitive current was evident in the myocytes from TA, but not in myocytes from the afferent arteriole. Figures 5C and 5G depict the time-dependent effects of kurtoxin on the initial peak I Ba in both cell types, whereas figures 5D and 5H show its effect on the currents measured at 100 ms. To account for run down, data from time controls (n=4-5) in which measurements were made in the absence of kurtoxin are depicted as filled symbols in these figures. In TA myocytes, kurtoxin significantly suppressed the peak current by 36.8±6.6% (p=0.005, Fig.5G ), whereas the effect was seen on I Ba at the end of 100 ms was indistinguishable from the time controls (Fig.5H) . No significant effects of kurtoxin were observed on either peak or 100 ms I Ba in afferent myocytes ( Fig.5C and 5D ).
The efferent arteriole is an unusual blood vessel, in that contractile responses are not affected by selective L-type Ca 2+ channel blockers 4, 23 or by hyperpolarization. 11 Similarly, depolarization has no effect on tone or calcium entry in this vessel. [8] [9] [10] Conversely, based on responses to non-selective agents that preferentially block T-type channels, it has been suggested that T-type Ca 2+ channels contribute to the activation of the efferent arteriole. 13, [23] [24] [25] In this study we were able to obtain the first measurements of I Ca and I Ba in myocytes from isolated efferent arterioles. We could not, however, maintain the whole-cell access long enough statistically compare full I-Vs in both conditions as in afferent myocytes. Therefore, the whole-cell currents were compared at a test potential to 0 mV. The current traces were leak-subtracted off-line, corrected for the cell size, averaged and compared in Fig.6 with the currents in afferent myocytes recorded under identical conditions. In 1.5 mmol/L Ca 2+ no measurable inward current was detected in efferent myocytes (Figs.6A and 6B ). With barium as the charge carrier, a small inward current was observed (Fig.6C) . However, similar to I Ca , it was significantly smaller compared to the afferent myocytes (-0.5±0.4 pA/pF, n=5, vs. -3.5±0.4 pA/pF, n=36) (Fig.6D) . Notably, as in afferent myocytes, the small I Ba seen in efferent myocytes did not display time dependent inactivation (Fig.6C ).
Discussion
The present study is the first to demonstrate and characterize voltage-activated Ca 2+ channel currents in myocytes isolated from native afferent and efferent arterioles using direct patchclamp techniques. Afferent arteriolar myocytes exhibited a relatively high density of L-type Ca 2+ currents and these currents could readily be measured in physiologic Ca
2+
. By contrast, efferent myocytes did not exhibit a measurable voltage-activated inward current under physiologic Ca 2+ conditions. These differences are unlikely due to difference in cell size and different rate of cell dialysis as the cell size (measured as C m ) was similar in both types of arterioles but was 5-fold less than that of TA myocytes which had significantly smaller I Ca and I Ba density then AA myocytes. We could not demonstrate the presence of a measurable Ttype Ca 2+ current in myocytes from either the afferent or efferent arteriole. These findings support the results of previous studies demonstrating the differing sensitivities of the afferent and efferent arterioles to specific L-type Ca 2+ channel blocking agents. [3] [4] [5] [6] 26 Conversely, our findings do not support the premise that T-type Ca 2+ channels directly contribute to the activation of either vessel. A number of laboratories have demonstrated that non-selective T-type channel inhibitors such as mibefradil, efonidipine or pimozide are capable of blocking contractile responses of both afferent and efferent arterioles (see review 13 ) and it is suggested that these channels contribute to the activation of both vessels. It must be emphasized, however, that this premise is supported by indirect observations and relies exclusively on contractile responses. In contrast, our conclusions are based on the 16, 17, 19 including conduit vessels of the kidney. 21 To address this concern, all myocytes isolated from TA and afferent arterioles and studied with the same protocol were included in our comparative analysis in contrast to previous studies in which exemplary cells expressing either T-or L-type currents were normally compared.
The electrophysiological and pharmacological approaches we used were sufficient to demonstrate the presence of both T-and L-type Ca 2+ currents in myocytes isolated from the rat tail artery, but not in similarly treated populations of afferent myocytes. Using the key biophysical properties of the T-type Ca 2+ channels, such as fast inactivating kinetics and more negative voltage range of their activation and inactivation, our analysis clearly demonstrates the presence of all these features in TA myocytes, but not in afferent myocytes (Figures 2-3 ).
The electrophysiological evidence is fully supported by the pharmacological separation of the two type Ca 2+ currents in TA myocytes using the selective L-type Ca 2+ channel inhibitor nifedipine and a relatively selective T-type blocker kurtoxin which at 200 nmol/L does not significantly affect the L-type currents 27 (Figures 4-5) . Furthermore, a significant leftward shift in the steady-state activation dependency for I Ba remaining in 1 µmol/L nifedipine in TA, but not in afferent, myocytes (Fig.4E ) provides further argument against the presence of the T-type currents in the renal afferent myocytes.
Although we did not observe T-type Ca 2+ currents in these vessels, the expression of the Ca V 3.1 and Ca V 3.2 genes of the T-type Ca 2+ channels has been demonstrated in the rat renal afferent arterioles isolated from the superficial regions of the renal cortex or from juxtamedullary nephrons and in the outer medullary vasa recta. 12 We, therefore, cannot rule out the presence of a small, beyond the electrophysiological detection level, T-type current in the afferent arteriole. However, it would be difficult to directly compare protein expression between the two cell types using immunocytochemistry without understanding molecular nature of the T-type Ca 2+ channels in TA myocytes which has not been established, and is outside the scope of this study. Furthermore, immunocytochemical analysis using antiCa V 3.1, antiCa V 3.2 and antiCa V 3.3 antibodies in vascular SMCs has proven to be inconclusive.
28,29
Functionally, we found that the L-type Ca 2+ current is rather prominent in afferent arteriolar myocytes with the peak I Ca density measured at physiologic Ca 2+ was approximately twice that of TA myocytes (Figures 1-2 15 Moreover, using the fura-2/manganese quench technique, we have previously shown that angiotensin II activates a voltage-independent and nifedipineinsensitive Ca 2+ entry in this vessel. 8 The molecular mechanisms and the type(s) of ion channels involved are however not known and require further focused studies.
In the mouse conversely to the rat, Poulsen and co-workers recently reported that potassiuminduced depolarization elicits a transient vasoconstriction in isolated efferent arterioles. 7 Since our studies and those cited above were conducted using rat arterioles, the possibility of species differences in the expression of Ca 2+ channels in the efferent arteriole cannot be ruled out. We also cannot exclude a possibility that afferent and efferent arterioles from juxtamedullary nephrons may express L-and T-type channels in different proportions compared to the superficial cortical arterioles studied in this paper, thus explaining a greater sensitivity of perfused juxtamedullary arterioles to non-specific T-type channel blockers like mibefradil or pimozide. 24 Alternatively, the action of at least some inhibitors may be explained by their action elsewhere due to their lack of specificity via, for example, effects on endothelial channels. 33, 34 To our knowledge, the renal microvascular effects of kurtoxin, which is considered to be the most specific T-type Ca 2+ channel blocker as our study also 
